Open AccessPhase II Study of Preoperative Concurrent Chemoradiotherapy with S-1 plus Bevacizumab for Locally Advanced Resectable Rectal Adenocarcinoma
Author(s) -
Sotaro Sadahiro,
Toshiyuki Suzuki,
Akira Tanaka,
Kazutake Okada,
Gota Saito,
Akemi Kamijo,
Takeshi Akiba,
Shuichi Kawada
Publication year - 2014
Publication title -
oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.987
H-Index - 98
eISSN - 1423-0232
pISSN - 0030-2414
DOI - 10.1159/000367972
Subject(s) - medicine , bevacizumab , surgery , colorectal cancer , abdominoperineal resection , rash , gastroenterology , cancer , chemotherapy
A single-arm phase II clinical trial was conducted to evaluate the safety and efficacy of preoperative chemoradiotherapy (CRT) with concurrent S-1, bevacizumab, and radiation in patients with locally advanced rectal cancer (LARC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom